Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China flag China · Delayed Price · Currency is CNY
21.55
-0.15 (-0.69%)
Sep 23, 2026, 3:04 PM CST

Wuhan Hvsen Biotechnology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,7241,6811,2001,0201,023996.22
Revenue Growth
8.68%40.07%17.71%-0.31%2.68%28.14%
Gross Profit
600.06518.76194.72210.65222.75268.51
Operating Income
308.93279.4718.356.5761.01135.28
Net Income
341.73253.16-20.1616.7852.71132.87
Earnings Per Share
1.641.29-0.120.100.320.80
EPS Growth
88.42%---68.27%-60.25%-21.41%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northeast China
61.152.6252.7243.3645.1
North China
307.65174.97125.285.8776.87
East China
408.59316.78288.81331.94336.97
South China
251.57209.59186.08202.8211.25
Central China
345.41253.37213.86217.75192.61
Northwest China
58.5641.741.6539.0533.87
Southwest China
88.4687.986.6489.9486.68
Export
159.9163.3924.7912.212.87
Total
1,6811,2001,0201,023996.22

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
573.18470.53527.11597.87785.721,098
Total Debt
463.83228.6888.56842.24790.45680.98
Net Cash (Debt)
109.36241.93-361.45-244.38-4.72417.47
Net Cash Growth
-33.21%-----41.03%
Net Cash Per Share
0.521.23-2.18-1.47-0.032.52

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
242.87238.4543.5392.9296.68155.72
Capital Expenditures
-279.83-96.92-194.43-184.31-428.87-600.12
Free Cash Flow
-36.96141.53-150.89-91.39-332.18-444.4
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
34.81%30.86%16.22%20.66%21.78%26.95%
Operating Margin
17.92%16.62%1.53%0.64%5.96%13.58%
Pretax Margin
22.55%17.17%-2.41%1.22%5.54%15.14%
Profit Margin
19.82%15.06%-1.68%1.65%5.15%13.34%
FCF Margin
-2.14%8.42%-12.57%-8.96%-32.48%-44.61%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.6000.3000.1060.2700.3000.331
Dividend Per Share Growth
142.22%181.91%-60.59%-10.00%-9.37%21.11%
Dividend Yield
2.78%1.48%1.09%1.97%1.58%1.27%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
13.2616.51-140.8963.6835.64
Forward PE
19.2020.5320.9630.4420.96-
P/FCF Ratio
-29.53----
PS Ratio
2.522.491.382.323.284.75